glp 1 weight loss results by week New lowest weight. Nothing else new to report. 🙃, #beforeandafterweightloss #glp1 #beforeandafter #weightloss #weightlossjourney GLP-1 Weight Loss & Loose

According to FDA prescribing information, the most frequent gastrointestinal side effects for semaglutide 2.4 mg (Wegovy) include: Nausea (44% of patients) Diarrhea (30% of patients) Vomiting (24% of patients) Constipation (24% of patients) Abdominal pain (20% of patients) Dyspepsia or indigestion (9% of patients) For tirzepatide (Zepbound), similar gastrointestinal effects occur, with rates varying by dose

How to prevent preeclampsia Preventing preeclampsia and other pregnancy complications starts before becoming pregnant

The image itself appears to be a real patient photo, but the shared use across clinics is weird

In terms of what GLP-1 use looks like in Canada, a 2026 Leger Healthcare survey estimated that about 8 per cent of Canadian adults, or roughly 3 million people, currently take a prescription GLP-1

Or the hazard or peril itself